Daniel Slíva
Impact in
- Pharmacology top 0.2%
- Fungal Biology and Applications
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in
- Pharmacology 34
- Fungal Biology and Applications 33
-
- Protease and Inhibitor Mechanisms 7
- Co-authors
- Jiahua Jiang (18 shared papers)Veronika Slivova (13 shared papers)Andrej Jedinak (13 shared papers)Shailesh P. Dudhgaonkar (6 shared papers)Tatiana Valachovicova (7 shared papers)Kevin A. Harvey (9 shared papers)Shujie Cheng (8 shared papers)Denis K. English (5 shared papers)
- Journals
- International Journal of Oncology (13 papers)Biochemical and Biophysical Research Communications (7 papers)Integrative Cancer Therapies (4 papers)PLoS ONE (3 papers)Mini-Reviews in Medicinal Chemistry (3 papers)
- Partner nations
- United StatesSwedenCzechia
In The Last Decade
Daniel Slíva
77 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 1.8k
- Cancer Research 358
- Complementary and alternative medicine 245
- Drug Discovery 7
- Oncology 529
Countries citing papers authored by Daniel Slíva
This map shows the geographic impact of Daniel Slíva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Slíva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Slíva more than expected).
Fields of papers citing papers by Daniel Slíva
This network shows the impact of papers produced by Daniel Slíva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Slíva. The network helps show where Daniel Slíva may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Slíva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 410 | |
| 2 | 2017 | 319 | |
| 3 | 2015 | 263 | |
| 4 | 2009 | 165 | |
| 5 | 2003 | 163 | |
| 6 | 1995 | 152 | |
| 7 | 2005 | 152 | |
| 8 | 2002 | 140 | |
| 9 | 2008 | 139 | |
| 10 | 2004 | 130 | |
| 11 | 2002 | 125 | |
| 12 | 2004 | 117 | |
| 13 | 2010 | 116 | |
| 14 | 2011 | 113 | |
| 15 | 2004 | 108 | |
| 16 | 2004 | 103 | |
| 17 | 2006 | 97 | |
| 18 | 2004 | 93 | |
| 19 | 2009 | 92 | |
| 20 | 2008 | 88 |
About Daniel Slíva
Daniel Slíva is a scholar working on Pharmacology, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 77 papers that have together received 4.9k indexed citations. Recurring topics across this work include Fungal Biology and Applications (33 papers), Protease and Inhibitor Mechanisms (7 papers), Mechanisms of cancer metastasis (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), Cancer Cells and Metastasis (4 papers), Sphingolipid Metabolism and Signaling (4 papers), Medicinal Plant Research (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). The work is most often cited by research in Pharmacology (1.8k citations), Cancer Research (358 citations), Complementary and alternative medicine (245 citations), Drug Discovery (7 citations) and Oncology (529 citations). Daniel Slíva has collaborated with scholars based in United States, Sweden and Czechia. Frequent co-authors include Jiahua Jiang, Veronika Slivova, Andrej Jedinak, Shailesh P. Dudhgaonkar, Tatiana Valachovicova, Kevin A. Harvey, Shujie Cheng, Denis K. English, Frank P. Lloyd and Andrea Čumová. Their work appears in journals such as International Journal of Oncology, Biochemical and Biophysical Research Communications, Integrative Cancer Therapies, PLoS ONE and Mini-Reviews in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.